Website maintenance is scheduled for Saturday, October 12, and Sunday, October 13. Short disruptions may occur during these days.

brand logo

Am Fam Physician. 2023;108(1):85-86

Author disclosure: No relevant financial relationships.

Clinical Question

Is trigger point injection therapy an effective treatment for low back pain?

Evidence-Based Answer

Trigger point injections with lidocaine or saline can be used for patients presenting to the emergency department with acute low back pain. (Strength of Recommendation: B, consistent, small randomized controlled trials [RCTs].) Trigger point injections, compared with intravenous nonsteroidal anti-inflammatory drugs (NSAIDs) or standard care, reduce pain by 2 to 3 points on a 10-point pain scale, decrease the length of stay in the emergency department by two hours, and decrease the short-term need for opioids by almost 50%.

Evidence Summary

A 2019 RCT of 54 adults in Turkey compared the effectiveness of trigger point injections to intravenous NSAIDs.1 Participants presented to the emergency department with at least one trigger point as the cause of acute low back pain. Trigger points were diagnosed using the Delphi consensus criteria of a taut band, hypersensitive spot, and referred pain. One physician performed trigger point injections in the treatment group using a mixture of 2% lidocaine and saline. The comparison group received 50 mg of dexketoprofen (not available in the United States) in 100 mL of isotonic solution over five minutes. Visual analog scale (VAS) scores for pain on a 0 to 10 scale were obtained at zero, five, 10, 15, 30, and 60 minutes. At zero minutes, the mean VAS scores were similar in both groups (7.6 vs. 7.2; P = .339). At all other time intervals, the mean pain scores in the intervention group were significantly lower than in the NSAID group (five minutes; 2.8 vs. 6.2; P < .001), and this difference in pain persisted throughout the study (60 minutes; 0.4 vs. 2.6; P < .0001).

Already a member/subscriber?  Log In

Subscribe

From $165
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

Clinical Inquiries provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group (https://www.cebm.net).

The complete database of evidence-based questions and answers is copyrighted by FPIN. If interested in submitting questions or writing answers for this series, go to https://www.fpin.org or email questions@fpin.org.

Copyright © Family Physicians Inquiries Network. Used with permission.

This series is coordinated by John E. Delzell Jr., MD, MSPH, associate medical editor.

A collection of FPIN’s Clinical Inquiries published in AFP is available at https://www.aafp.org/afp/fpin.

Continue Reading

More in AFP

More in PubMed

Copyright © 2023 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.